BASEL, Switzerland, Oct 2 (Reuters) - Swiss pharmaceuticals company Roche Holding AG (ROG.VX: Quote, Profile, Research) named a new head to its diagnostics division on Tuesday and boosted the standing of its diabetes activities within the group. Basel-based Roche said Juergen Schwiezer, 62, would become head of its diagnostics division, replacing Severin Schwan, whose appointment to group CEO was previously announced.
